Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 612

Results For "AP"

7865 News Found

Eight Roads announce US $ 250 million healthcare fund for India
News | May 17, 2022

Eight Roads announce US $ 250 million healthcare fund for India

This new fund is amongst the largest for the sector in India


Covestro to showcase material solutions from wound care to wearable smart patches
Medical Device | May 17, 2022

Covestro to showcase material solutions from wound care to wearable smart patches

Wearable patch sensors (smart patches) are rising in popularity, as they offer a wide range of options for medical diagnosis


BDR Pharma receives Rs. 685 crore of PE investment
News | May 17, 2022

BDR Pharma receives Rs. 685 crore of PE investment

Multiples is the first private equity (PE) investor in the company


BenevolentAI achieves third milestone in its AI-enabled drug discovery collaboration with AstraZeneca
Biotech | May 17, 2022

BenevolentAI achieves third milestone in its AI-enabled drug discovery collaboration with AstraZeneca

A total of three targets have been selected for portfolio entry in the collaboration to date, with the potential to generate further future development milestones and sales-based royalty revenues for BenevolentAI


Sahajanand Medical Technologies win award for Supraflex Cruz
Medical Device | May 17, 2022

Sahajanand Medical Technologies win award for Supraflex Cruz

Union Minister of State for Science and Technology, Dr Jitendra Singh gave the award for the successful commercialization of indigenous technology on National Technology Day 2022


AbbVie and Cugene announce collaboration in autoimmune diseases
News | May 16, 2022

AbbVie and Cugene announce collaboration in autoimmune diseases

AbbVie receives the option to license worldwide rights to CUG252 from Cugene, a clinical-stage and potential best-in-class Treg-selective IL-2 mutein, building on AbbVie's commitment to developing novel therapies in immunology


Boehringer Ingelheim’s treatment slowed lung function decline in people living with idiopathic pulmonary fibrosis
Biotech | May 16, 2022

Boehringer Ingelheim’s treatment slowed lung function decline in people living with idiopathic pulmonary fibrosis

Potential new treatment for progressive pulmonary fibrosis (PPF) builds on Boehringer Ingelheim’s leadership in lung fibrosis and will be further investigated in a phase III clinical trial program


Antengene announces commercial availability of Xpovio in China
Biotech | May 16, 2022

Antengene announces commercial availability of Xpovio in China

The drug will be available in 600 hospitals and 105 DTPs


Inmagene receives USFDA IND clearance for a third-generation BTK inhibitor
Biotech | May 16, 2022

Inmagene receives USFDA IND clearance for a third-generation BTK inhibitor

It is developing the drug candidate to potentially treat immunological diseases